Related Experiment Video
Updated: Oct 2, 2025

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
Mycobacterium marinum Infection and Interferon-Gamma Release Assays Cross-Reactivity: A Case Report
Premalkumar M Patel1, Nicholas Camps1, Cynthia I Rivera1
1Infectious Disease, Mount Sinai Medical Center, Miami Beach, USA.
Abstract:
Mycobacterium marinum (M. marinum) is a pathogen that causes skin and soft tissue infections in people who work with contaminated water, such as fish handlers. M. marinum infection is mostly limited to patients with compromised immune systems. As per current guidelines, susceptibility testing is not routinely recommended, although sporadic cases have been reported with resistance to routinely prescribed anti-tuberculous drugs. We report a case of a 61-year-old male taking adalimumab with ulcerative skin and soft tissue infection with positive interferon-gamma release assays (IGRA) identified as M. marinum and the treatment challenges involved in this case.

